Physician profile
Nabil Mehta
NPI 1912490756
$14,642.90
in general payments reported to CMS, 2019-2025
12 companies · $596 in 2025
The $596 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.03 · 2020: $1,813 · 2021: $3,089 · 2022: $238 · 2023: $2,370 · 2024: $6,441 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,619 · Food and Beverage: $3,288 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,618.76 |
| Food and Beverage | $3,288.00 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $4,818.85 | 2023-2024 | Djo Surgical |
| Medwest Associates | $4,190.05 | 2020-2021 | |
| Stryker Corporation | $4,176.23 | 2020-2025 | Blueprint Patient Specific Instrumentation, Mako, Aequalis Perform Reversed |
| Medical Device Business Services, INC. | $456.21 | 2019-2023 | Inhance |
| Depuy Synthes Sales INC. | $421.60 | 2021-2023 | Na |
| Tricoast Surgical Solutions LLC | $236.49 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $168.37 | 2021 | |
| Smith+Nephew, INC. | $69.02 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Paladin Technology Solutions | $40.10 | 2023 | |
| Restor3d, INC. | $29.32 | 2025 | |
| Arthrosurface Incorporated | $22.47 | 2025 | Ovomotion |
| Prytime Medical Devices, INC. | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.